Global Cancer Diagnostics Market Growth with Worldwide Analysis: Trends, Opportunities and Forecasts (2016-2021)(By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker: By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography: By Region: North America, Latin America, APAC, Europe, MEA)
"Global
Cancer Diagnostics Market: Trends, Opportunities and Forecasts
(2016-2021)(By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker:
By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography:
By Region: North America, Latin America, APAC, Europe, MEA)"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Executive
Summary
Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market
Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population, where emerging markets are expected to achieve higher growth.
Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market
Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population, where emerging markets are expected to achieve higher growth.
Get
Sample
Report
With TOC @
http://www.researchmoz.us/enquiry.php?type=S&repid=760225
Given
the growing demand for early detection of cancer, tumor marker tests
are gaining prominence and are projected to witness stronger growth
in the coming years.
Growth in the incidences of cancer across the globe is due to the sedentary lifestyle such as increasing tobacco consumption and unhealthy eating habits.
Advancement in genomics has resulted in the growing cancer research, due to which early detection of cancer is gaining popularity.
Global Cancer Diagnostics Market is forecasted to grow at a CAGR of 8.8% during 2016 2021F, on account of rising incidences of cancer globally, along with the increasing technological advancement driven by focus on cancer research
North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by countries such as India and China.
According to Azoth Analytics research report, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, Global Cancer Diagnostics Market has been segmented by type (By Type: Imaging Tests, Endoscopy, Biopsy and Tumor Marker, By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography, By Region: North America, Latin America, APAC, Europe and MEA.)
Scope of the Report
The report provides Segmentation by Type
Imaging Tests
Endoscopy
Biopsy
Tumor Marker
The report provides Segmentation by Sub- Type
Imaging Tests : MRI, Ultrasound, PET-CT Scan, Mammography
The report provides coverage by Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)
Customization of the Report
The report could be customized according to the clients specific research requirements. No additional cost will be required to pay for limited additional research.
Growth in the incidences of cancer across the globe is due to the sedentary lifestyle such as increasing tobacco consumption and unhealthy eating habits.
Advancement in genomics has resulted in the growing cancer research, due to which early detection of cancer is gaining popularity.
Global Cancer Diagnostics Market is forecasted to grow at a CAGR of 8.8% during 2016 2021F, on account of rising incidences of cancer globally, along with the increasing technological advancement driven by focus on cancer research
North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by countries such as India and China.
According to Azoth Analytics research report, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, Global Cancer Diagnostics Market has been segmented by type (By Type: Imaging Tests, Endoscopy, Biopsy and Tumor Marker, By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography, By Region: North America, Latin America, APAC, Europe and MEA.)
Scope of the Report
The report provides Segmentation by Type
Imaging Tests
Endoscopy
Biopsy
Tumor Marker
The report provides Segmentation by Sub- Type
Imaging Tests : MRI, Ultrasound, PET-CT Scan, Mammography
The report provides coverage by Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)
Customization of the Report
The report could be customized according to the clients specific research requirements. No additional cost will be required to pay for limited additional research.
Table
of Contents
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
3.1. North America and Europe to drive the Cancer Diagnostic Market
3.2. Lung, Breast, Bowel and Prostrate Cancers to remain the major cause of Cancer Diagnostics
3.3. Cancer Imaging Test would form the largest market segment for Cancer Diagnosis
4. Global Cancer Diagnostics Market: An Overview
4.1. Product Overview
4.1.1.Global Cancer Diagnostics Market, By Value 2011-2015
4.1.2.Global Cancer Diagnostics Market, By Value 2016-2021F
Global Cancer Diagnostics Market: By Type (Imaging Tests, Endoscopy, Biopsy, Tumour Marker Tests)
4.1. Global Imaging Tests Market
4.1.1.By Value (Historic 2011-15)
4.1.2.By Value (Forecast 2016E-2021F)
4.1.3.By Sub-Type - Ultrasound, PET-CT Scan, Mammography, MRI (By Value 2016E-2021F)
4.2. Global Endoscopy Cancer Diagnostics Market
4.2.1.By Value (Historic 2011-15)
4.2.2.By Value (Forecast 2016E-2021F)
4.3. Global Biopsy Market
4.3.1.By Value (Historic 2011-15)
4.3.2.By Value (Forecast 2016E-2021F)
4.4. Global Tumour Marker Tests Market
4.4.1.By Value (Historic 2011-15)
4.4.2.By Value (Forecast 2016E-2021F)
4.5. Global Imaging Test Market, By Region, By Value (2016E-2021F)
5. North America Cancer Diagnostics Market: An Overview
5.1. North America Cancer Diagnostics Market
5.1.1.By Value (Historic 2011-15)
5.1.2.By Value (Forecast 2016E-2021F)
5.2. North America Cancer Diagnostics Country Overview USA, Canada
6. APAC Cancer Diagnostics Market: An Overview
6.1. APAC Cancer Diagnostics Market
6.1.1.By Value (Historic 2011-15)
6.1.2.By Value (Forecast 2016E-2021F)
6.2. APAC Cancer Diagnostics Country Overview India, China
7. Europe Cancer Diagnostics Market: An Overview
7.1. Europe Cancer Diagnostics Market
7.1.1.By Value (Historic 2011-15)
7.1.2.By Value (Forecast 2016E-2021F)
7.2. Europe Cancer Diagnostics Country Overview Denmark, UK
8. Latin America Cancer Diagnostics Market: An Overview
8.1. Latin America Cancer Diagnostics Market
8.1.1.By Value (Historic 2011-15)
8.1.2.By Value (Forecast 2016E-2021F)
8.2. Latin America Cancer Diagnostics Country Overview Chile, Brazil
9. MEA Cancer Diagnostics Market: An Overview
9.1. MEA Cancer Diagnostics Market
9.1.1.By Value (Historic 2011-15)
9.1.2.By Value (Forecast 2016E-2021F)
9.2. MEA Cancer Diagnostics Country Overview UAE
10. Market Dynamics
10.1. Market Trends & Developments
10.2. Market Drivers
10.3. Challenges
11. Policy Regulations
12. SWOT Analysis
13. Porter Five Force Model
14. Company Profiling
14.1. Abbott Laboratories
14.2. Becton Dickinson and Company
14.3. F. Hoffmann-La Roche AG (Roche Diagnostics)
14.4. General Electric Co (General Healthcare)
14.5. Thermo Fisher Scientific
14.6. Agilent Technologies, Inc.
14.7. Illumina, Inc.
14.8. Hologic Inc.
14.9. C. R. Bard Inc.
15 About us & Disclaimer
List of Chart
Figure 1: Global Cancer Diagnostics Market, 2011-2015 (USD Billion)
Figure 2: Global Population Above 65 Percentage of Total Population
Figure 3: Major Cancer Among Women
Figure 4: Major Cancer Among Men
Figure 5: Estimated Cancer Incidences (approx.14 million) in 2012 with Regional Breakup
Figure 6: Estimated Cancer Mortality (approx. 8 million) in 2012 with Regional Breakup
Figure 7: Global Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
Figure 8: Global Population Above 65 (in Million)
Figure 9: Global Cancer Diagnostic Imaging Test Market, By Value, 2011-2021F (in USD Billion)
Figure 10: Global Imaging Test Market, By Sub-Type, By Value, 2016E (In Percentage)
Figure 11: Global Imaging Test Market, By Sub-Type, By Value, 2021F (In Percentage)
Figure 12: Ultrasound Cancer Diagnostics Market, By Value, 2011-2021F (in USD Million)
Figure 13: PET-CT Scan Market, By Value, 2011-2021F (in USD Million)
Figure 14: Global Mammography Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Figure 15: MRI Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Figure 16: Endoscopy Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Figure 17: Biopsy Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Figure 18: Tumour Marker Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Figure 19: Global Imaging Test Market, By Region, By Value, 2016E (In Percentage)
Figure 20: Global Imaging Test Market, By Region, By Value2021F (In Percentage)
Comments
Post a Comment